№ files_lp_3_process_9_08307
File format: docx
Character count: 8168
File size: 86 KB
Pathogen details (Gram-positive, Gram-negative, Other Organisms)
Note:
Facility ID
Event Type:
UTI
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Facility ID
Year:
Not specified
Country:
United States
Document Type:
Surveillance reporting form
Subject:
Laboratory-identified MDRO or Clostridioides difficile infection events
Applicable Setting:
Long-term care facility (LTCF)
Issuing Authority:
Centers for Disease Control and Prevention (CDC)
Legal Framework:
Public Health Service Act Sections 304, 306 and 308(d) (42 USC 242b, 242k, 242m(d))
OMB Control Number:
0920-0666
Form Number:
CDC 57.138
Revision:
rev 4, v9.4
Estimated Reporting Burden:
15 minutes per response
Data Collected:
Resident identifiers, admission dates, organism type, specimen details, care location, transfer status, antibiotic therapy, demographic information
Confidentiality Statement:
Information collected under guarantee of strict confidence for public health surveillance purposes
Year:
Not specified
Month/Year:
To be completed by facility
Facility ID:
To be completed by facility
Document Type:
Monthly reporting form
Subject:
Healthcare Associated Infection (HAI) surveillance and prevention measures
Infection Types:
UTI; Laboratory-identified Event (LabID Event)
Organism Data:
Specific Organism Type; All Specimens
Prevention Measures:
Hand Hygiene; Gown and Gloves Use
COVID-19 Module:
Healthcare Personnel COVID-19 Vaccination Summary; Resident COVID-19 Vaccination Summary
Scope:
Facility-wide Inpatient (FacWideIN)
Confidentiality Basis:
Public Health Service Act Sections 304, 306 and 308(d) (42 USC 242b, 242k, 242m(d))
Responsible Authority:
Centers for Disease Control and Prevention (CDC)
OMB Control Number:
0920-0666
Form Number:
CDC 57.141 (Front), v7.0
Estimated Reporting Burden:
5 minutes per response
Submission Contact:
CDC Project Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333
Year:
2021
Region / City:
United States
Topic:
Healthcare, COVID-19, Long-term Care Facilities
Document Type:
Instructional Guide
Organization:
Centers for Disease Control and Prevention (CDC)
Author:
Centers for Disease Control and Prevention (CDC)
Target Audience:
Healthcare Providers, Long-term Care Facilities
Effective Period:
January 2021
Approval Date:
January 2021
Modification Date:
None
Year:
2026
Region / City:
United States
Theme:
Healthcare / Infection Control
Document Type:
Medical Record
Organization / Institution:
CDC
Author:
CDC
Target Audience:
Healthcare Providers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Last Modification:
Not specified
Version:
2.0
Year:
2025
Region / city:
[location/service/organisation]
Topic:
Urinary Tract Infection, Nitrofurantoin, PGD (Patient Group Direction)
Document type:
PGD (Patient Group Direction)
Organization:
UKHSA
Author:
Dr. Diane Ashiru-Oredope, Dr. Imran Jawaid, Dr. Kiren Collison, Dr. Naomi Fleming, Mandy Slatter, Jo Jenkins, Kieran Reynolds, Liz Cross, Professor Bhaskar Somani, Temitope Odetunde, Tracy Rogers
Target audience:
Registered healthcare professionals authorized by their organization
Effective date:
1st January 2026
Review date:
30th June 2028
Expiry date:
31st December 2028
Approval body:
UKHSA HCAI & AMR Division
Document version history:
1.0 (January 2023), 1.1 (July 2023), 1.2 (February 2024), 1.3 (April 2024), 1.4 (January 2025), 2.0 (October 2025)
PGD reviewed by:
National UTI antimicrobial PGD Short Life Working Group
Context:
This document outlines a Patient Group Direction for the use of nitrofurantoin in the treatment of urinary tract infections, specifying authorized practitioners and legal requirements.
Year:
2023
Region / City:
United Kingdom
Topic:
Healthcare, UTI Diagnosis
Document Type:
Guideline
Organization / Institution:
UKHSA
Author:
Nina S et al.
Target Audience:
Care home staff, primary care providers
Period of Action:
October 2023
Approval Date:
October 2023
Date of Changes:
Not specified
Year:
Not specified
Region / City:
Not specified
Subject:
Acute uncomplicated urinary tract infection (UTI) treatment
Document Type:
Patient Group Direction (PGD)
Author:
Not specified
Target Audience:
Healthcare professionals, community pharmacy staff
Effective Period:
Not specified
Approval Date:
Not specified
Revision Date:
Not specified
Year:
N/A
Region / City:
N/A
Subject:
Acute Urinary Tract Infection Treatment
Document Type:
Patient Group Direction
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Healthcare professionals, pharmacists
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
2024
Field:
Rehabilitation Medicine; Urology; Spinal Cord Injury Research
Document Type:
Scientific Research Article
Authors:
Rochelle E. Tractenberg; Suzanne L. Groah; Sarah DiMeglio; Lance Goetz; Todd Linsenmeyer; Bonne Lee; Michael Kennelly; Claus Moser; Jürgen Pannek; Fin Biering-Sørensen
Affiliated Institutions:
Georgetown University Medical Center; MedStar National Rehabilitation Hospital; Hunter Holmes McGuire VA Medical Center; Kessler Institute for Rehabilitation; Prince of Wales Hospital; Charlotte Institute of Rehabilitation; Rigshospitalet; University of Copenhagen; Swiss Paraplegic Centre; Inselspital Bern University Hospital
Supporting Organization:
National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)
Funding Award:
90SIMS009-01-00
Geographic Scope:
International
Subject:
Diagnostic criteria and standardized clinical data collection for urinary tract infection in individuals with spinal cord injury
Related Data Standards:
International Spinal Cord Injury Data Sets
Methodology:
Three-phase qualitative design including phenomenographic analysis, expert member-check, and international expert discussion
Key Outcome:
Revised urinary tract infection basic data set including additional variables for standardized global data collection
Corresponding Author:
Rochelle E. Tractenberg
Contact Email:
[email protected]
Year:
2012
Region / City:
United States
Subject:
Medical Protocol
Document Type:
Clinical Guidelines
Institution:
Infectious Diseases Society of America
Author:
Stone ND, Nicolle LE et al.
Target Audience:
Healthcare Professionals
Effective Period:
Ongoing
Date of Approval:
2012
Date of Changes:
N/A
Topic:
Antibiotic prescribing for urinary tract infections (UTI)
Document type:
Training presentation action plan
Program / Initiative:
TARGET (Treat Antibiotics Responsibly, Guidance, Education, Tools)
Subject area:
Antimicrobial stewardship
Clinical focus:
Urinary tract infection diagnosis and treatment
Key objectives:
Reduce use of 3Cs antibiotics, improve UTI diagnosis, reduce dipstick use in elderly patients, increase Nitrofurantoin prescribing
Recommended practices:
Use diagnostic flow charts, prioritize Nitrofurantoin in clinical systems, avoid dipsticks in patients over 65, send urine cultures when resistance is suspected, distribute UTI patient information leaflets
Responsible roles:
Clinicians, practice manager, antibiotic champion, reception staff, locum clinicians
Practice activities:
Antibiotic audit with action planning, prescribing data review at staff debriefs, adaptation of telephone triage flowchart for UTI
Implementation timeframe:
Preparations before World Antibiotic Awareness Week (18 November)
Associated materials:
TARGET UTI patient information leaflets, TYI-RTI leaflet, educational posters
Review schedule:
Sore throat prescribing audit review planned in 6 months
Year:
2023
Region:
New Zealand
Topic:
Antimicrobial Stewardship, Urinary Tract Infections
Document type:
Webinar transcript
Organization:
Te Tāhū Hauora Health Quality & Safety Commission
Author:
Claire Underwood
Target audience:
Aged residential care professionals
Period:
23 February 2023
Video link:
https://www.youtube.com/watch?v=oOig8RNX2TM&list=PLqL5-6uWOmWfnW6mTl7BBSe3hSomPqXO5&index=4
Key subjects:
Ngā Paerewa standards, infection prevention, AMS programs, UTI management policies, staff and whānau education
Year:
2025
Region / city:
Victoria, Australia
Topic:
Health, Urinary Tract Infection, Pharmacist Services
Document type:
Patient handout
Author:
Department of Health, Victoria Government
Target audience:
Women and gender diverse people with female biology aged 18-65, including Medicare and international students
Period of validity:
December 2025
Approval date:
December 2025
Date of updates:
Not specified
Year:
2023
Region / City:
New Zealand
Subject:
Medical referral for Stress Urinary Incontinence (SUI) treatment
Document Type:
Medical Referral Form
Institution:
Manatū Hauora (Health Ministry)
Author:
Not specified
Target Audience:
Healthcare professionals (Referring clinicians, specialists)
Period of Application:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Description:
Form for referring patients with stress urinary incontinence for multidisciplinary discussion and evaluation, including medical history, symptoms, diagnostic tests, and treatment options.
Year:
2024
Region / City:
Wales
Topic:
Healthcare, Pharmacy, Urinary Tract Infection
Document Type:
Patient Group Directions (PGD)
Organisation:
Welsh Medicines Advice Service, NHS Wales
Author:
Dianne Burnett, Louise Allen, Emlyn Pritchard, Adam Mackridge, Richard Coulthard
Target Audience:
Healthcare professionals, community pharmacists
Validity Period:
From 03 June 2024 to 02 June 2027
Approval Date:
22 April 2024
Ratification Date:
09 May 2024
Review Date:
08 February 2027
Expiry Date:
02 June 2027
Version:
1.0
Change History:
Version 1.0 developed on 22 December 2023
Clinical Condition:
Acute, uncomplicated lower urinary tract infection
Treatment:
Nitrofurantoin, Trimethoprim
Applicable Group:
Non-pregnant females or transgender males (16-64 years)
Authorising Organisation:
Local Health Board
Staff Requirements:
Registered pharmacists, authorised by name
Retention Period:
8 years for adults, 25 years for children
Local Inquiries:
[insert local details]
Year:
2024
Region / city:
Victoria, Australia
Topic:
Urinary Tract Infection Treatment
Document Type:
Patient Handout
Organ / Institution:
Department of Health, Victoria
Author:
Department of Health, Victoria
Target Audience:
Women and gender diverse people with female biology aged 18-65
Period of validity:
March 2024
Approval date:
March 2024
Date of amendments:
N/A
Contextual Description:
Patient handout providing details about treatment, eligibility, and self-care for uncomplicated urinary tract infection under a pilot program for community pharmacists.
Note:
Year
Subject:
Healthcare Plan, Risk Management
Document Type:
Healthcare Plan
Target Audience:
Individuals at risk of urinary tract infections
Year:
2023
Region / City:
Canberra
Topic:
Healthcare Procedure
Document Type:
Procedure Manual
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Healthcare professionals (nurses, doctors, allied health staff)
Period of validity:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified